GT Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 868 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 501-509 of 509 matching filings.

Per page
25
Current page
21
3

PRIMARY DOCUMENT

Filing date
25 Mar 2010
Reporting date
23 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
22 Mar 2010
Reporting date
11 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
22 Mar 2010
Reporting date
11 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS CURRENT REPORT

Filing date
15 Mar 2010
Reporting date
08 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS CURRENT REPORT

Filing date
05 Mar 2010
Reporting date
01 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-32837

SCHEDULE 13D

Filing date
22 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-32837

AMENDED SCHEDULE 2

Filing date
16 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS 8-K 02-02-2010

Filing date
16 Feb 2010
Reporting date
10 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

OXIS 8-K 01-15-10

Filing date
20 Jan 2010
Reporting date
15 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .